Support PenkeXbrane Biopharma AB - Trending symbols
Latest News of Xbrane Biopharma AB
| Date | Title | Read |
|---|---|---|
| 2025-10-28 06:35 | 3 European Growth Companies With Insiders Owning Up To 12% | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| Death Cross | Death Cross | 2025-11-06 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Long-term Liabilities | 125,161 | -19,800 | 105,361 | -9,410 | 95,951 | -28,848 | 67,103 | -67,104 | -1 | |
| Long-term Assets Other | 1 | 3,944 | 3,945 | 0 | 3,945 | -3,944 | 1 | -2 | -1 | |
| Income before Tax | -97,106 | 26,906 | -70,200 | 25,379 | -44,821 | 3,518 | -41,303 | 60,550 | 19,247 | |
| Net Income | -97,405 | 26,903 | -70,502 | 25,387 | -45,115 | -8,082 | -53,197 | 61,361 | 8,164 | |
| Operating Income | -89,276 | 25,611 | -63,665 | 26,243 | -37,422 | 5,726 | -31,696 | 59,357 | 27,661 | |
| Net Income from Continuing Operations | -97,106 | 26,906 | -70,200 | 25,379 | -44,821 | -8,071 | -52,892 | 72,139 | 19,247 | |
| EBITDA | -76,039 | 12,373 | -63,666 | 34,808 | -28,858 | 5,847 | -23,011 | 50,672 | 27,661 | |
| Depreciation and Amortization | 7,594 | 528 | 8,122 | 9,160 | 17,282 | -8,183 | 9,099 | -9,100 | -1 | |
| Cost of Revenue | 39,632 | 15,106 | 54,738 | 7,919 | 62,657 | -48,805 | 13,852 | -27,237 | -13,385 | |
| Net Debt | -124,808 | -30,966 | -155,774 | 77,374 | -78,400 | 8,105 | -70,295 | 144,412 | 74,117 | |
| Net Interest Income | -623 | 334 | -289 | -298 | -587 | -1,347 | -1,934 | 10,705 | 8,771 | |
| Total Other Income Expense Net | -622 | 331 | -291 | -296 | -587 | -1,347 | -1,934 | 10,705 | 8,771 | |
| Other Current Assets | 1 | 246,237 | 246,238 | -176,251 | 69,987 | 351 | 70,338 | -70,339 | -1 | |
| Other Liabilities | 3,544 | 4,848 | 8,392 | 329 | 8,721 | 4,346 | 13,067 | -13,068 | -1 | |
| Interest Income | 1,260 | -472 | 788 | -57 | 731 | -78 | 653 | -1,276 | -623 | |
| Other Operating Expenses | -3,451 | -145 | -3,596 | 87 | -3,509 | -958 | -4,467 | 4,572 | 105 | |
| Discontinued Operations | -1,506 | 0 | -1,506 | 0 | -1,506 | 0 | -1,506 | 1,963 | 457 |
Comments
How you think about this?